A post-hoc analysis of phase II and III trials published in the Journal of Rheumatology revealed that tofacitinib (TOF) was more effective than placebo in ...
A recent multicenter, randomized clinical trial published in JAMA Network Open has highlighted the potential of mycophenolate mofetil (MMF) in reducing the risk of severe ...
In a recent study published in Clinical Rheumatology, anti-α-1,4-D-polygalacturonic acid (PGA) antibodies have emerged as a promising biomarker for juvenile idiopathic arthritis (JIA), potentially reshaping ...
A recent study published in Rheumatic and Musculoskeletal Diseases (RMD) Open has demonstrated the long-term safety and efficacy of ozoralizumab, a novel anti-TNF multivalent variable ...
Image Type: Dermatomyositis Body Site: Skin Description It is an idiopathic inflammatory myopathy affecting both children and adults. It primarily involves the skin and ...
In a significant development for patients with psoriatic arthritis (PsA), the dual interleukin (IL)-17A and IL-17F inhibitor, bimekizumab has shown remarkable effectiveness in reducing disease ...
A groundbreaking study published in Cureus identified miRNA-122-5p (miR-122-5p) as a potential biomarker that could revolutionize the diagnosis and treatment of individuals suffering from both ...
A long-term follow-up study, EDITA-ON, published in Arthritis Research & Therapy has provided compelling evidence that ambrisentan therapy significantly reduces the risk of developing pulmonary ...
A groundbreaking study published in PLOS ONE has revealed a potential bidirectional link between gut microbiota and ankylosing spondylitis (AS), providing new insights into the ...
Dr. Sampath Rangasamy spoke about the role of inflammation in microvascular diabetic complications. Ang-2 is an important pro-inflammatory and provasopermeability agent in DR ... Read more
Dr. K. Gokulakrishnan discussed the adipose tissue and brain – The neuroinflammatory link. Neuroinflammation appears to be the cornerstone of the different factors contributing ... Read more
Dr. Chandrashekara. S discussed the Immune-Mechanism of Autoimmune related Inflammatory Diseases of Skin. Skin is not a protective layer but also an active organ ... Read more
Autoimmune-mediated inflammatory skin disorder- introduction to clinical variety was discussed by Dr. Shekhar Neema. Pemphigus group of disorders and urticaria are the B cell ... Read more
Dr. Swaminathan Sethu discussed the immune-mechanism unique to ophthalmic-associated inflammations. The basic mechanism in ocular conditions is that immune privilege to dampen the general inflammation ... Read more
The talk on primary immunodeficiency focuses on recognizing signs like recurrent infections, failure to thrive, and unusual infections for early suspicion. It highlights the need ... Read more
Dr. Chandrashekara. S discussed the use of autoantibodies in the diagnosis of Rheumatic diseases. Monoclonal antibodies have a higher chance of detecting the exact antigen ... Read more
Dr. Chandrashekara. S discussed the precautions before administration of tofacitinib. Jak inhibitors are Pan cytokines blocker that impairs the immune system functioning effectively. Incidence of ... Read more
Dr. Rajkiran Dudam spoke about the tofacitinib indications and their use in rheumatology. Tofacitinib comes with lots of expectations and its generics are widely ... Read more
Dr. Puja Srivastava discussed the concept of JAK inhibitor utility in the management of autoimmune diseases. Activation of the JAK-STAT Signal transduction pathway is a ... Read more
Dr. Namita Dave discussed the imaging in uveitis: the bigger picture on inflammation. The methods used in the anterior eye segment imaging are slit ... Read more
Dr. Roshmi Gupta discussed orbital inflammation and the perspective of an ophthalmologist. Orbital inflammation is a proptosed, and painful red eye, with reduced ocular ... Read more
Dr. Sanjay S spoke about intermediate uveitis. Inflammation in the vitreous humor, ciliary body, or peripheral retina is known as intermediate uveitis. Treatment of ... Read more
Dr. Padmamalini discussed the clinical clues in the differential diagnosis of anterior uveitis. A detailed history and a thorough clinical examination remain the ... Read more
Clinical evaluation of episcleritis & scleritis and interpretation of the differential diagnosis of episcleritis and scleritis were discussed by Dr. Ankush. AS- angiography helps ... Read more
A post-hoc analysis of phase II and III trials published in the Journal of Rheumatology revealed that tofacitinib (TOF) was more effective than placebo in ... Read more
A recent multicenter, randomized clinical trial published in JAMA Network Open has highlighted the potential of mycophenolate mofetil (MMF) in reducing the risk of severe ... Read more
In a recent study published in Clinical Rheumatology, anti-α-1,4-D-polygalacturonic acid (PGA) antibodies have emerged as a promising biomarker for juvenile idiopathic arthritis (JIA), potentially reshaping ... Read more
A recent study published in Rheumatic and Musculoskeletal Diseases (RMD) Open has demonstrated the long-term safety and efficacy of ozoralizumab, a novel anti-TNF multivalent variable ... Read more
In a significant development for patients with psoriatic arthritis (PsA), the dual interleukin (IL)-17A and IL-17F inhibitor, bimekizumab has shown remarkable effectiveness in reducing disease ... Read more
A groundbreaking study published in Cureus identified miRNA-122-5p (miR-122-5p) as a potential biomarker that could revolutionize the diagnosis and treatment of individuals suffering from both ... Read more
![[Day-2]Virtual Bi-Monthly Lecture series – 5 on Immunology and Inflammation](/wp-content/uploads/2022/02/Virtual-Bi-Monthly-Lecture-Series-on-IMMUNOLOGY-AND-INFLAMMATION-768x432.jpg)
